rs200922655

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_001195248.2(APTX):​c.484-25_484-5delGTTTTTTTTTTTGTTTTTTTT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.278 in 1,277,180 control chromosomes in the GnomAD database, including 14,600 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 7125 hom., cov: 0)
Exomes 𝑓: 0.27 ( 7475 hom. )

Consequence

APTX
NM_001195248.2 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.13

Publications

4 publications found
Variant links:
Genes affected
APTX (HGNC:15984): (aprataxin) This gene encodes a member of the histidine triad (HIT) superfamily. The encoded protein may play a role in single-stranded DNA repair through its nucleotide-binding activity and its diadenosine polyphosphate hydrolase activity. Mutations in this gene have been associated with ataxia-ocular apraxia. Alternatively spliced transcript variants have been identified for this gene.[provided by RefSeq, Aug 2010]
APTX Gene-Disease associations (from GenCC):
  • ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 9-32986034-AAAAAAAAACAAAAAAAAAAAC-A is Benign according to our data. Variant chr9-32986034-AAAAAAAAACAAAAAAAAAAAC-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 198285.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.472 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
APTXNM_001195248.2 linkc.484-25_484-5delGTTTTTTTTTTTGTTTTTTTT splice_region_variant, intron_variant Intron 4 of 7 ENST00000379817.7 NP_001182177.2 Q7Z2E3-7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
APTXENST00000379817.7 linkc.484-25_484-5delGTTTTTTTTTTTGTTTTTTTT splice_region_variant, intron_variant Intron 4 of 7 1 NM_001195248.2 ENSP00000369145.2 Q7Z2E3-7

Frequencies

GnomAD3 genomes
AF:
0.421
AC:
44470
AN:
105626
Hom.:
7126
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.328
Gnomad AMI
AF:
0.557
Gnomad AMR
AF:
0.430
Gnomad ASJ
AF:
0.524
Gnomad EAS
AF:
0.248
Gnomad SAS
AF:
0.296
Gnomad FIN
AF:
0.442
Gnomad MID
AF:
0.436
Gnomad NFE
AF:
0.477
Gnomad OTH
AF:
0.443
GnomAD2 exomes
AF:
0.263
AC:
38489
AN:
146242
AF XY:
0.261
show subpopulations
Gnomad AFR exome
AF:
0.197
Gnomad AMR exome
AF:
0.252
Gnomad ASJ exome
AF:
0.334
Gnomad EAS exome
AF:
0.122
Gnomad FIN exome
AF:
0.303
Gnomad NFE exome
AF:
0.301
Gnomad OTH exome
AF:
0.292
GnomAD4 exome
AF:
0.266
AC:
311082
AN:
1171552
Hom.:
7475
AF XY:
0.261
AC XY:
152703
AN XY:
586162
show subpopulations
African (AFR)
AF:
0.189
AC:
4795
AN:
25432
American (AMR)
AF:
0.220
AC:
6855
AN:
31152
Ashkenazi Jewish (ASJ)
AF:
0.310
AC:
6475
AN:
20866
East Asian (EAS)
AF:
0.111
AC:
3929
AN:
35548
South Asian (SAS)
AF:
0.137
AC:
9419
AN:
68740
European-Finnish (FIN)
AF:
0.245
AC:
9541
AN:
38982
Middle Eastern (MID)
AF:
0.271
AC:
912
AN:
3360
European-Non Finnish (NFE)
AF:
0.286
AC:
256542
AN:
898394
Other (OTH)
AF:
0.257
AC:
12614
AN:
49078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.409
Heterozygous variant carriers
0
10729
21458
32188
42917
53646
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9482
18964
28446
37928
47410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.421
AC:
44465
AN:
105628
Hom.:
7125
Cov.:
0
AF XY:
0.416
AC XY:
21038
AN XY:
50558
show subpopulations
African (AFR)
AF:
0.328
AC:
9345
AN:
28496
American (AMR)
AF:
0.430
AC:
4525
AN:
10530
Ashkenazi Jewish (ASJ)
AF:
0.524
AC:
1425
AN:
2720
East Asian (EAS)
AF:
0.248
AC:
689
AN:
2780
South Asian (SAS)
AF:
0.295
AC:
797
AN:
2698
European-Finnish (FIN)
AF:
0.442
AC:
2512
AN:
5684
Middle Eastern (MID)
AF:
0.435
AC:
87
AN:
200
European-Non Finnish (NFE)
AF:
0.477
AC:
23992
AN:
50252
Other (OTH)
AF:
0.442
AC:
656
AN:
1484
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1328
2656
3983
5311
6639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
436
872
1308
1744
2180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.283
Hom.:
259

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 09, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Dec 02, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 09, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Coenzyme Q10 deficiency, Oculomotor Apraxia Type Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia Benign:1
Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.1
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200922655; hg19: chr9-32986032; API